INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Rethinking Trial Access Through Trust-Driven Design And Local Collaboration
Locally embedded research models help sponsors reach underserved populations while reducing burden on patients and health systems alike.
-
Ergomed's Solutions To The Challenges of Oncology Trials
Explore a pivotal Phase III global clinical trial investigating neoadjuvant immunotherapy for locally advanced squamous cell carcinoma of the head and neck (LA SCCHN).
-
Are You Paying Participants Enough? Your Top Questions Answered
Explore key themes surrounding payments to clinical research participants in depth, with a particular focus on the role of participant compensation and best practices in payment logistics.
-
2025 Clinical Trial Payment Tax Implications Explained
Flat-rate clinical trial payments are often taxable in the U.S., while reimbursements are not. Unclear tax rules can impact participant trust, site communication, and trial retention.
-
The Vendor Selection Blunder: An Expensive Oversight In Clinical Trials10/21/2025
Vendor selection isn’t just procedural — it shapes trial outcomes. Even with a solid process, missteps can ripple through timelines, budgets, and team morale. Choose wisely.
-
Challenges That Derail Bladder Cancer Trials And How To Anticipate Them Earlier3/5/2026
From the rapid evolution of standard-of-care benchmarks to the logistical strain of procedure-heavy urology workflows, the path to a successful endpoint is filled with operational friction.
-
Why Asia Should Be Your Next Trial Destination10/17/2025
Many U.S. oncology sponsors are expanding their late-phase trials into Asia to secure access to rich patient pools, leverage efficient regulatory pathways, and save time and money in the clinic.
-
6 Steps To Help You Choose The Right Clinical Trial Partner9/12/2025
The right digital partner can unlock speed, scale, and collaboration that can transform the future of your pipeline. Learn the six steps to help you choose the right partner for your trials.
-
How To Optimize Early-Phase Drug Development10/16/2024
Do you keep hitting roadblocks? Frustrated with all the paperwork? Let us help! Learn how Altasciences can provide a more seamless and efficient drug development experience.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
With over 60 HAP studies successfully conducted in the last decade, Altasciences has experience in diverse areas such as for stimulants, opioids, and sedative-hypnotics.
-
PCI's team of qualified persons assume responsibility for all stages of the process, safeguarding patients including the audit of the supply chain for GMP compliance in addition to certification of products for use in clinical trials.
-
Discover how Scout supports patient retention with people-first solutions for reimbursement and travel at no cost to sites.
-
With integrations at the heart of our efficiency model, Block Clinical automates payments in three areas: Site Payments, Patient Payments, and Supplier Payments.
-
Our mission is grounded in urgency and purpose: to shorten the time it takes for innovative blood cancer treatments to reach the patients and families who cannot afford to wait.